This study aims to understand how your genes might affect your body's response to cancer treatments, including potential side effects or how well treatments work. Researchers will collect a blood or cheek swab sample from you to analyze your DNA. They are looking for genetic differences that could explain why some people react differently to cancer medications. This information could help doctors personalize cancer treatments in the future. You can join if you are at least 3 years old, have cancer, and are currently receiving treatment as part of an NIH intramural research program clinical trial. The study is ongoing and plans to include 1100 participants.

Study design

This is an observational study that plans to enroll 1,100 participants. It is an exploratory study designed to look for connections between genetic variations and how the body handles medications.

What's involved

You will provide a blood sample for analysis. If you have blood-based cancer, you will provide a cheek swab sample instead. An additional sample may be collected if the first one doesn't have enough genetic material.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, which is obtaining and analyzing genomic DNA, is measured at the duration of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.